CEPI is supporting PATH's work as part of an international consortium developing a new egg-based vaccine to tackle COVID-19, inspired by influenza vaccines in longtime use.
Programme forms part of CEPI’s efforts to develop “next-generation” COVID-19 vaccines
Up to 23,000 participants will be enrolled into the research programme in Benin, Guinea, Liberia, and Sierra Leone, as well as Nigeria, which began collecting data in December 2020.
CEPI’s early investment in Clover has been key to accelerating development and equitable access to this promising vaccine.
The UK will host a summit with the Coalition for Epidemic Preparedness Innovations (CEPI) – a leading scientific coalition – to raise funds for vaccine research and development. The 2022 summit will support the UK and CEPI’s goal of cutting vaccine development time by two-thirds, to 100 days, which could avert future pandemics and save...
CEPI’s five-year plan sets out ambitious initiatives to build a future world that is better equipped to deal with these devastating diseases.
Governments and global health bodies expressed support for CEPI's $3.5 billion plan to dramatically reduce or even eliminate the future risk of pandemics and epidemics.